4.89
前日終値:
$4.78
開ける:
$4.78
24時間の取引高:
863.81K
Relative Volume:
0.71
時価総額:
$433.63M
収益:
$73.48M
当期純損益:
$-108.30M
株価収益率:
-2.1733
EPS:
-2.25
ネットキャッシュフロー:
$-67.17M
1週間 パフォーマンス:
+1.24%
1か月 パフォーマンス:
-12.37%
6か月 パフォーマンス:
+15.33%
1年 パフォーマンス:
-15.69%
Personalis Inc Stock (PSNL) Company Profile
PSNL を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
PSNL
Personalis Inc
|
4.89 | 423.88M | 73.48M | -108.30M | -67.17M | -2.25 |
![]()
TMO
Thermo Fisher Scientific Inc
|
492.72 | 184.93B | 43.21B | 6.58B | 6.17B | 17.29 |
![]()
DHR
Danaher Corp
|
205.82 | 147.00B | 24.01B | 3.41B | 4.86B | 4.70 |
![]()
IDXX
Idexx Laboratories Inc
|
647.09 | 51.77B | 4.04B | 985.66M | 774.34M | 12.01 |
![]()
A
Agilent Technologies Inc
|
125.66 | 35.50B | 6.63B | 1.17B | 1.19B | 4.05 |
![]()
IQV
Iqvia Holdings Inc
|
190.81 | 32.08B | 15.70B | 1.24B | 2.01B | 6.91 |
Personalis Inc Stock (PSNL) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-05-15 | 開始されました | Guggenheim | Buy |
2025-03-17 | 開始されました | Craig Hallum | Buy |
2023-02-06 | アップグレード | Needham | Hold → Buy |
2022-01-07 | アップグレード | BofA Securities | Neutral → Buy |
2021-11-05 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
2021-11-03 | ダウングレード | Needham | Buy → Hold |
2021-10-15 | 再開されました | Cowen | Outperform |
2021-09-20 | 繰り返されました | Needham | Buy |
2021-05-06 | アップグレード | Oppenheimer | Perform → Outperform |
2021-01-28 | 開始されました | Truist | Buy |
2021-01-04 | ダウングレード | BofA Securities | Buy → Neutral |
2020-11-12 | 繰り返されました | Needham | Buy |
2020-11-06 | ダウングレード | Oppenheimer | Outperform → Perform |
2020-10-19 | 開始されました | Citigroup | Buy |
2020-10-08 | 開始されました | BTIG Research | Buy |
2020-08-27 | 開始されました | H.C. Wainwright | Buy |
2020-08-18 | 開始されました | Needham | Buy |
2019-09-26 | アップグレード | BofA/Merrill | Neutral → Buy |
2019-07-15 | 開始されました | BofA/Merrill | Neutral |
2019-07-15 | 開始されました | Cowen | Outperform |
2019-07-15 | 開始されました | Morgan Stanley | Overweight |
2019-07-15 | 開始されました | Oppenheimer | Outperform |
すべてを表示
Personalis Inc (PSNL) 最新ニュース
Signal strength of Personalis Inc. stock in tech scannersEarnings Trend Report & Safe Capital Growth Trade Ideas - Newser
Chart based analysis of Personalis Inc. trendsMarket Risk Summary & Safe Capital Growth Stock Tips - Newser
Personalis Inc. stock trend outlook and recovery pathPortfolio Value Summary & Consistent Income Trade Recommendations - Newser
Is Personalis Inc. reversing from oversold territoryTrend Reversal & Daily Technical Forecast Reports - Newser
Is Personalis Inc. stock ready for a breakout2025 Market Overview & Precise Buy Zone Tips - Newser
Advanced analytics toolkit walkthrough for Personalis Inc.2025 Major Catalysts & Real-Time Price Movement Reports - Newser
Tools to assess Personalis Inc.’s risk profile2025 Price Momentum & AI Enhanced Trading Signals - Newser
Can a trend reversal in Personalis Inc. lead to recoveryWeekly Stock Report & Smart Swing Trading Techniques - Newser
Is Personalis Inc. showing signs of accumulationQuarterly Profit Summary & Long-Term Capital Growth Ideas - Newser
Technical signs of recovery in Personalis Inc.2025 Top Gainers & AI Enhanced Trading Alerts - Newser
How to escape a deep drawdown in Personalis Inc.July 2025 Levels & Reliable Breakout Forecasts - Newser
What makes Personalis Inc. stock price move sharplyWeekly Risk Report & AI Based Buy and Sell Signals - Newser
Will Personalis Inc. benefit from green energy policiesEarnings Growth Report & Consistent Profit Trade Alerts - sundaytimes.kr
Full technical analysis of Personalis Inc. stockMarket Growth Summary & Free Low Drawdown Momentum Trade Ideas - Newser
News impact scoring models applied to Personalis Inc.July 2025 Price Swings & High Accuracy Trade Signal Alerts - Newser
Personalis Inc. stock momentum explainedTrade Analysis Summary & AI Enhanced Market Trend Forecasts - Newser
Personalis Inc (PSNL) 財務データ
収益
当期純利益
現金流量
EPS
Personalis Inc (PSNL) インサイダートレーディング
インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
---|---|---|---|---|---|---|---|
Tachibana Aaron | CFO AND COO |
Jul 28 '25 |
Sale |
6.57 |
641 |
4,211 |
164,458 |
Tachibana Aaron | CFO AND COO |
May 16 '25 |
Sale |
4.95 |
1,291 |
6,390 |
165,099 |
Moore Stephen Michael | SVP and Chief Legal Officer |
May 16 '25 |
Sale |
4.95 |
1,675 |
8,291 |
64,200 |
Chen Richard | CHIEF MEDICAL OFFICER AND EVP |
May 16 '25 |
Sale |
4.95 |
910 |
4,504 |
124,957 |
Tachibana Aaron | CFO AND COO |
Jan 28 '25 |
Sale |
5.79 |
708 |
4,099 |
166,390 |
Chen Richard | CHIEF MEDICAL OFFICER AND EVP |
Jan 28 '25 |
Sale |
5.79 |
519 |
3,005 |
123,367 |
Chen Richard | CHIEF MEDICAL OFFICER AND EVP |
Dec 16 '24 |
Sale |
3.82 |
4,834 |
18,466 |
123,886 |
Moore Stephen Michael | SVP and Chief Legal Officer |
Dec 16 '24 |
Sale |
3.82 |
1,513 |
5,780 |
65,875 |
Tachibana Aaron | CFO AND COO |
Dec 16 '24 |
Sale |
3.82 |
6,865 |
26,224 |
167,098 |
Tachibana Aaron | CFO AND COO |
Nov 18 '24 |
Sale |
3.79 |
1,307 |
4,954 |
173,963 |
大文字化:
|
ボリューム (24 時間):